KZIA
USDKazia Therapeutics Limited American Depositary Shares
$11.430+1.190 (11.621%)
Real-time Price
Healthcare
Biotechnology
Australia
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$10.240
High
$12.000
Low
$10.117
Volume
0.15M
Company Fundamentals
Market Cap
15.5M
Industry
Biotechnology
Country
Australia
Trading Stats
Avg Volume
1.11M
Exchange
NCM
Currency
USD
52-Week Range
Low $2.86Current $11.430High $39.05
Related News
PR Newswire
Cancer Innovation Accelerates as Funding Cuts Loom and Biotechs Step Up
USA News Group News Commentary – Cancer rates are rising everywhere, but more dramatically in some places. According to a new analysis of CDC data,...
View more
PR Newswire
Kazia Therapeutics Reports Early Efficacy Data from First Triple-Negative Breast Cancer Patient Receiving Paxalisib Combination Regimen achieving >50% Reduction in Circulating Tumor Cells in Phase 1b Trial
Kazia Therapeutics (NASDAQ: KZIA) is pleased to announce preliminary results from the first patient in its Phase 1b trial evaluating a combination...
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.